Skip to main content
Premium Trial:

Request an Annual Quote

NCGR Licenses KeyGene's Profiling Technology

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – KeyGene and the National Center for Genome Resources, located in San Jose, NM, have inked a non-exclusive license agreement giving NCGR rights to market and conduct sequence-based mapping projects using KeyGene's Whole Genome Profiling (WGP) technology.

NCGR will combine its sequencing and informatics capabilities with the WGP technology, which is based on generating short read sequences of pooled BAC clones produced by KeyGene's partner Amplicon Express.

Wageningen, Netherlands-based KeyGene's technology uses sequence tags to assemble BAC clones at high stringency based on shared regions containing identical sequence tags. The WGP map forms a scaffold for assembling whole genome sequence data from a range of organisms.

"Many of our de novo genome projects will benefit from the WGP platform through guiding the order and orientation of our next-generation DNA sequencing-based scaffolds," NCGR President Gregory May said in a statement.

"We believe that this agreement will give a much larger customer base access to better genome assemblies that can be used as reference genomes and to support molecular breeding activities," added KeyGene's US-based VP of Business Development Mark van Haaren.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.